Informative of Surface Electromyography and Prognostic Factors in Assessing the Recovery of Balance and Gait After Stroke
Launched by LITHUANIAN UNIVERSITY OF HEALTH SCIENCES · Jul 27, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how a special test called surface electromyography (EMG) can help us understand how well people recover their balance and walking after having a stroke. The researchers want to find out what factors might predict a patient’s chance of improving in these areas during their rehabilitation, which is the second stage of recovery after a stroke.
To participate, individuals must be between 18 and 89 years old and have had their first stroke, known as a cerebral infarction. They should be able to walk on their own and have some muscle strength. Participants will need to provide their consent to join the study. If chosen, they can expect to undergo assessments that will help both their recovery process and contribute to our understanding of stroke rehabilitation. This trial is currently recruiting participants, and it's an opportunity to help advance knowledge in stroke recovery while receiving support for their own rehabilitation journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cerebral infarction for the first time;
- • Age from 18 to 89 years old;
- • Muscle strength according to the Oxford scale is 3-5 points;
- • Able to walk without the help of others;
- • Is able to communicate and understand instructions properly;
- • Agrees to participate in the study (voluntary, explicit, informed written consent to participate).
- Exclusion Criteria:
- • Muscle strength according to the Oxford scale is 0-2 points;
- • Unable to walk without the help of others;
- • Sensorimotor aphasia or other perceptual disorders;
- • Do not sign the informed consent.
About Lithuanian University Of Health Sciences
The Lithuanian University of Health Sciences (LSMU) is a leading academic institution dedicated to advancing health sciences through innovative research and education. With a strong emphasis on interdisciplinary collaboration, LSMU conducts clinical trials aimed at improving patient outcomes and enhancing healthcare practices. The university's commitment to rigorous scientific inquiry is complemented by its state-of-the-art facilities and a network of experienced professionals, making it a pivotal player in the field of medical research in Lithuania and beyond. Through its clinical trials, LSMU strives to contribute valuable insights to the global medical community while fostering the next generation of healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaunas, , Lithuania
Patients applied
Trial Officials
Eglė Lendraitienė, PhD
Principal Investigator
LUHS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials